Neratinib

Red

Brand Name(s):Nerlynx

Indication:Early-stage hormone receptor positive HER2-overexpressed/amplified breast cancer who have completed adjuvant trastuzumab-based therapy <1 year ago

Rationale:1,2

Considered:Oct-19

Review Date:Oct-24

Comments: